The Center for Health Information and Analysis would be authorized to collect data on PBMs and issue regulations to better collect information from them and to help the state understand cost ...

The second analysis showed that while no specific antipsychotic offered greater cognitive benefit, first-generation dopamine blockers fared worse for preserving attention, concentration, and memory.

I’ve covered high drug prices as a reporter for years. ... He told me the drug passes any cost-benefit analysis because of its impact on multiple myeloma patients like myself.

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

Starting Jan. 1, the redesigned drug benefit will operate more like other private insurance policies. Coverage begins after patients pay a deductible, which will be no more than $590 next year.

Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating a rapidly ...

After calling for a major discount for Pfizer’s popular transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis, a U.S. drug cost watchdog has provided a final analysis that includes a ...

The pharma blister packaging machines market share analysis is poised for substantial expansion between 2025 and 2035.

The difference between the AWP cost of a drug and the cost of that same drug on the NADAC can be significant. For example, a generic drug may have an AWP price of $100 but a NADAC price of $15.

MA lawmakers send Healey bill to cap some drug costs, regulate pharmacy benefit ... share any of the cost of a generic drug, ... for Pharmaceutical Policy and Analysis within the Health ...